If I was running BP I would buy it now but I believe 100% approval is going to happen and believe you can settle with generics 100%. However, if you buy it now and those 2 things do not work out you'd be crucified by shareholders so why not wait a few months, and buy it slightly more once de-risked a little? Would Amarin really sell for much less today than they would in January?
News 
Market Data 
Discover 
